Policosanol

	WikiDoc Resources for Policosanol
Articles
Most recent articles on Policosanol Most cited articles on Policosanol Review articles on Policosanol Articles on Policosanol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Policosanol Images of Policosanol Photos of Policosanol Podcasts & MP3s on Policosanol Videos on Policosanol
Evidence Based Medicine
Cochrane Collaboration on Policosanol Bandolier on Policosanol TRIP on Policosanol
Clinical Trials
Ongoing Trials on Policosanol at Clinical Trials.gov Trial results on Policosanol Clinical Trials on Policosanol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Policosanol NICE Guidance on Policosanol NHS PRODIGY Guidance FDA on Policosanol CDC on Policosanol
Books
Books on Policosanol
News
Policosanol in the news Be alerted to news on Policosanol News trends on Policosanol
Commentary
Blogs on Policosanol
Definitions
Definitions of Policosanol
Patient Resources / Community
Patient resources on Policosanol Discussion groups on Policosanol Patient Handouts on Policosanol Directions to Hospitals Treating Policosanol Risk calculators and risk factors for Policosanol
Healthcare Provider Resources
Symptoms of Policosanol Causes & Risk Factors for Policosanol Diagnostic studies for Policosanol Treatment of Policosanol
Continuing Medical Education (CME)
CME Programs on Policosanol
International
Policosanol en Espanol Policosanol en Francais
Business
Policosanol in the Marketplace Patents on Policosanol
Experimental / Informatics
List of terms related to Policosanol

Policosanol
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C10AX08 (WHO) ;
Identifiers
	IUPAC name Octacosanol, triacontanol, etc.;
CAS Number	142583-61-1 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	CH3-(CH2)n-CH2OH n=24-34
Molar mass	(variable)
(verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

PolicosanolTemplate:Pronunciation-needed (or polycosanol) is the generic term for a natural mixture of long chain alcohols extracted from plant waxes. It is used as a nutritional supplement intended to lower LDL cholesterol ("bad" cholesterol) and increase HDL cholesterol ("good" or "healthy" cholesterol) and to help prevent atherosclerosis, though some studies have raised questions about the effectiveness of policosanol.

Physical properties

Policosanol is a mixture of a few fatty alcohols derived from the waxes of such plants as sugar cane^[1] and yams, as well as beeswax. The most prevalent alcohol in policosanol is octacosanol,^[2] followed by triacontanol.

There is a much lower concentration of several other fatty alcohols: behenyl alcohol, lignoceryl alcohol, ceryl alcohol, 1-heptacosanol, 1-nonacosanol, 1-dotriacontanol, and geddyl alcohol.

Modulation of HMG-CoA reductase^[3] and bile acid absorption inhibition^[4] have been proposed as mechanisms.

Studies

Published studies have come to conflicting conclusions regarding the efficacy of policosanol in lowering LDL (i.e., "bad cholesterol") or raising HDL (i.e., "good cholesterol").,^[5]^[6]^[7] despite a number of studies funded by the Cuban government, which produces and markets the drug.^[8] Older independent clinical trials found no evidence of the efficacy of policosanol,^[5] while more recent studies have found effect.

External Links

Policosanol at PDRHealth.com
U.S. Patent 6,225,354

References

↑ Marinangeli CP, Kassis AN, Jain D, Ebine N, Cunnane SC, Jones PJ (2007). "Comparison of composition and absorption of sugarcane policosanols" (abstract). Br. J. Nutr. 97 (2): 381–8. doi:10.1017/S0007114507336763. PMID 17298709.
↑ Ohta Y, Ohashi K, Matsura T, Tokunaga K, Kitagawa A, Yamada K (2008). "Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride". J Clin Biochem Nutr. 42 (2): 118–25. doi:10.3164/jcbn.2008017. PMC 2266062. PMID 18385828.
↑ Singh DK, Li L, Porter TD (2006). "Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase". J. Pharmacol. Exp. Ther. 318 (3): 1020–6. doi:10.1124/jpet.106.107144. PMID 16714400.
↑ Ng CH, Leung KY, Huang Y, Chen ZY (2005). "Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters". J. Agric. Food Chem. 53 (16): 6289–93. doi:10.1021/jf051269a. PMID 16076108.
↑ ^5.0 ^5.1 Heiner K. Berthold, MD, PhD; Susanne Unverdorben, MD; Ralf Degenhardt, PhD; Michael Bulitta, Dipl-Stat; Ioanna Gouni-Berthold, MD (May 17, 2006). "Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined Hyperlipidemia". Journal of the American Medical Association. 295 (19): 2262–2269. doi:10.1001/jama.295.19.2262. PMID 16705107. Retrieved 2006-10-03.
↑ Pons P, Rodriguez M, Robaina C, Illnait J, Mas R, Fernandez L, Fernandez JC. (1994). "Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment". International Journal of Clinical Pharmacology Research. 14 (1): 27–33. PMID 7927958.
↑ Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G (2005). "Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol". Pharmacotherapy. 25 (2): 171–83. doi:10.1592/phco.25.2.171.56942. PMID 15767233.
↑ Thorsteinsdóttir, Halla; Sáenz, TW; Quach, U; Daar, AS; Singer, PA (2004). "Cuba—innovation through synergy". Nature Biotechnology. 22 (12s): DC19–DC24. doi:10.1038/nbt1204supp-DC19. PMID 15583679.

Template:Lipid modifying agents

[pmid17298709-1] Marinangeli CP, Kassis AN, Jain D, Ebine N, Cunnane SC, Jones PJ (2007). "Comparison of composition and absorption of sugarcane policosanols" (abstract). Br. J. Nutr. 97 (2): 381–8. doi:10.1017/S0007114507336763. PMID 17298709.

[pmid18385828-2] Ohta Y, Ohashi K, Matsura T, Tokunaga K, Kitagawa A, Yamada K (2008). "Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride". J Clin Biochem Nutr. 42 (2): 118–25. doi:10.3164/jcbn.2008017. PMC 2266062. PMID 18385828.

[pmid16714400-3] Singh DK, Li L, Porter TD (2006). "Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase". J. Pharmacol. Exp. Ther. 318 (3): 1020–6. doi:10.1124/jpet.106.107144. PMID 16714400.

[pmid16076108-4] Ng CH, Leung KY, Huang Y, Chen ZY (2005). "Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters". J. Agric. Food Chem. 53 (16): 6289–93. doi:10.1021/jf051269a. PMID 16076108.

[negative-5] 5.0 ^5.1 Heiner K. Berthold, MD, PhD; Susanne Unverdorben, MD; Ralf Degenhardt, PhD; Michael Bulitta, Dipl-Stat; Ioanna Gouni-Berthold, MD (May 17, 2006). "Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined Hyperlipidemia". Journal of the American Medical Association. 295 (19): 2262–2269. doi:10.1001/jama.295.19.2262. PMID 16705107. Retrieved 2006-10-03.

[positive-6] Pons P, Rodriguez M, Robaina C, Illnait J, Mas R, Fernandez L, Fernandez JC. (1994). "Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment". International Journal of Clinical Pharmacology Research. 14 (1): 27–33. PMID 7927958.

[pmid15767233-7] Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G (2005). "Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol". Pharmacotherapy. 25 (2): 171–83. doi:10.1592/phco.25.2.171.56942. PMID 15767233.

[8] Thorsteinsdóttir, Halla; Sáenz, TW; Quach, U; Daar, AS; Singer, PA (2004). "Cuba—innovation through synergy". Nature Biotechnology. 22 (12s): DC19–DC24. doi:10.1038/nbt1204supp-DC19. PMID 15583679.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]